flufenamic acid

Preferred Label : flufenamic acid;

MeSH definition : An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16);

MeSH synonym : acid, flufenamic;

MeSH hyponym : dignodolin;

MeSH CAS label : benzoic acid, 2-((3-(trifluoromethyl)phenyl)amino)-;

MeSH Related Number : 530-78-9 (Flufenamic acid);

Registry Number MeSH : 530-78-9;

Wikipedia link : https://en.wikipedia.org/wiki/Flufenamic acid;

Codes EINECS : 208-494-1;

Is substance : O;

UNII : 60GCX7Y6BH;

InChIKey : LPEPZBJOKDYZAD-UHFFFAOYSA-N;

Details

Origin ID

D005439;

UMLS CUI

C0016282;

ATC code(s)
- flufenamic acid [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- flufenamic acid [Substance BNPC]
Pharmacological action(s)
- anti-inflammatory agents [MeSH Descriptor]
Record concept(s)
- dignodolin [MeSH concept]
- flufenamic acid [MeSH concept]
Related MeSH Supplementary Concept(s)
- 5-hydroxyflufenamic acid [MeSH Supplementary Concept]
- aluminum flufenamate [MeSH Supplementary Concept]
- cholesteryl flufenamate [MeSH Supplementary Concept]
- dextran-flufenamic acid ester [MeSH Supplementary Concept]
- diethylamine salicylate, flufenamic acid, myrtecaine drug combination [MeSH Supplementary Concept]
- etofenamate [MeSH Supplementary Concept]
- flufenamic acid hydroxypropylamide [MeSH Supplementary Concept]
- mobilisin [MeSH Supplementary Concept]
- polyethyleneglycol diflufenamate [MeSH Supplementary Concept]
- triethylene glycol flufenamate [MeSH Supplementary Concept]
- ufenamate [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Flufenamic Acid [NCIt concept]
- Flufenamic acid [ICD-11 Extension code]
- Flufenamic acid (substance) [SNOMED CT concept]
- flufenamic acid [ATC Code]
- flufenamic acid [Substance BNPC]
Validated automatic mappings to BTNT
- flufenamic acid [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients